The Prostate · 2005 · 34 citations · 28 references
MedicineOncologyPharmacologyCancer PharmacologyEndocrine OncologySteroid BiochemistryAndrogen Deprivation TherapyAndrogen TherapyHormonal Cancer TherapyHormonal TherapyProstate CancerSteroid Hormone Signaling5-Alpha-reductase Inhibition5-Alpha-reductase Inhibitor TherapyAndrogen PharmacologyContinuous Androgen Deprivation TherapyFinasteride TherapyIntermittent Androgen Deprivation TherapyProstate Cancer Hormonal TherapyProstate Cancer Hormone Therapy
BACKGROUND: Intermittent androgen ablation (IAA) was developed with the intention of delaying progression of prostate cancer to androgen-independence and improving quality of life. Our previous studies suggest that relative to dihydrotestosterone (DHT), testosterone (T) is a weak inducer of proliferation and a more potent inducer of differentiation. We hypothesize that administration of finasteride (F), a type-II 5-alpha-reductase inhibitor that increases T and decreases DHT, during the IAA "off-cycle" would enhance the efficacy. METHODS: After LNCaP tumor establishment, nude mice were castrated and randomized to continuous androgen ablation (CAA), continuous androgen ablation plus finasteride (CAA + F), intermittent androgen ablation (IAA), or intermittent androgen ablation plus finasteride (IAA + F). RESULTS: After one cycle of therapy, mice treated with IAA + F had significantly less tumor growth than the other treatment groups (P = 0.002). Mice treated with IAA + F had the best survival (P = 0.048) and were 3-5 times more likely to be alive 70 days following treatment initiation. CONCLUSIONS: IAA with finasteride provides the most favorable tumor growth kinetics and survival compared to both CAA and standard IAA.
28
The Influence of Finasteride on the Development of Prostate Cancer
Ian M. Thompson, Phyllis J. Goodman, Catherine M. Tangen et al. · New England Journal of Medicine · 2003 · 2.5K citations · Full text
Jos Veldscholte, C. Ris-Stalpers, George G. J. M. Kuiper et al. · Biochemical and Biophysical Research Communications · 1990 · 945 citations · Full text
Tumor measurement in the nude mouse
David Euhus, Charles Hudd, Marie C. LaRegina et al. · Journal of Surgical Oncology · 1986 · 613 citations
Medicine, Oncology, Animal Anatomy +12